Cavernous liver hemangioma
Cavernous Liver Hemangioma is a benign vascular tumor of the liver, which is the largest solid organ in the human body. This type of hemangioma is typically a slow-growing or static mass that is composed of blood vessels. It is the most common type of benign liver tumor and is often discovered incidentally during imaging studies for unrelated reasons. Despite its benign nature, a cavernous liver hemangioma can sometimes present with symptoms, especially if it reaches a significant size.
Etiology and Pathogenesis[edit | edit source]
The exact cause of cavernous liver hemangioma is not well understood. It is believed to be congenital, meaning it is present at birth. The development of these tumors is thought to be related to vascular malformation during the embryonic stage of development. There is no known association with liver disease or liver function.
Clinical Presentation[edit | edit source]
Most individuals with cavernous liver hemangioma are asymptomatic. However, when symptoms do occur, they may include abdominal discomfort or pain, a feeling of fullness, nausea, or early satiety. These symptoms are generally due to the mass effect of the hemangioma pressing on adjacent structures within the abdomen. In rare cases, a cavernous liver hemangioma can rupture, leading to internal bleeding and potentially life-threatening complications.
Diagnosis[edit | edit source]
Cavernous liver hemangioma is most commonly diagnosed incidentally during imaging studies such as ultrasound, computed tomography (CT) scan, or magnetic resonance imaging (MRI) that are performed for other reasons. On imaging, these hemangiomas typically appear as well-defined, hypervascular lesions. Further diagnostic tests, including liver function tests and biopsy, may be performed to rule out malignancy and other liver conditions.
Treatment[edit | edit source]
The majority of cavernous liver hemangiomas do not require treatment and can be managed with observation. Regular follow-up imaging may be recommended to monitor the size of the hemangioma. In cases where the hemangioma is symptomatic, or there is a risk of complications such as rupture, treatment options may include surgical resection or minimally invasive procedures such as arterial embolization.
Prognosis[edit | edit source]
The prognosis for individuals with cavernous liver hemangioma is generally excellent, as these tumors are benign and have a very low risk of complications. Surgical intervention, when required, is typically successful.
Epidemiology[edit | edit source]
Cavernous liver hemangioma is the most common type of benign liver tumor, with a higher prevalence in adults than in children. It is more commonly diagnosed in women than in men, which may be related to hormonal factors.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD